The AHA, 340B Health, Maryland Hospital Association and Mid-Atlantic Association of Community Health Centers July 9 filed an amicus brief in a federal district court in Maryland, defending the state’s law protecting 340B pricing for contract pharmacy arrangements. AHA, 340B Health and the West Virginia Hospital Association last week filed a similar amicus brief in a federal district court in West Virginia.  
 
The AHA filed last month similar briefs in Maryland and Mississippi. On July 1, a Mississippi judge denied Novartis Pharmaceuticals’ and PhRMA’s request for a preliminary injunction against enforcement of Mississippi's law on 340B pricing protection for contract pharmacy arrangements.

Headline
The Centers for Medicare & Medicaid Services has released a fact sheet and FAQs on the 340B Part D claims data repository that will go live Oct. 1. Data…
Headline
The AHA Aug. 26 urged the Centers for Medicare & Medicaid Services not to finalize two proposals in the calendar year 2027 outpatient prospective payment…
Headline
The AHA Aug. 25 submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act),…
Headline
A bipartisan group of senators Aug. 5 introduced the Supporting Underserved and Strengthening Transparency, Accountability and Integrity Now and for the Future…
Headline
The Department of Health and Human Services today issued a notice announcing a revised 340B Rebate Model Pilot Program, allowing qualifying drug manufacturers…
Headline
The U.S. District Court for the District of Columbia July 21 upheld a lower court’s decision that Section 340B of the Public Health Service Act does not …